News

Contract Pharma8d
Overcoming Challenges in Early Phase Drug Product Development
Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...
Contract Pharma1d
Thermo Fisher Streamlines Pre-Clinical Biologic Drug Development
Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical ...
TMCnet7d
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the first patient has been dosed in ...
Morningstar6d
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody ... 1310 data at ASCO and outline the next steps in clinical development. Date/Time: Monday, June 2, 2025, at 7:00 a.m. CT ...